Biostar Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Net
Biostar Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Net of $5.38 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2017-11-20
- 2017-09-30: Finite-Lived Intangible Assets, Net $5.38M.
- 2017-06-30: Finite-Lived Intangible Assets, Net $5.42M.
- 2017-03-31: Finite-Lived Intangible Assets, Net $5.49M.
- 2016-12-31: Finite-Lived Intangible Assets, Net $5.61M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2017-09-30 | $5.38M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $5.42M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $5.49M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $5.61M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $6.06M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $6.28M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $6.74M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $6.88M 10-K · filed 2017-04-13 |
| 2015-09-30 | $11.73M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $12.69M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $12.99M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $13.27M 10-K · filed 2016-04-14 |
| 2014-09-30 | $14.93M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $15.67M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $16.38M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $17.13M 10-K · filed 2015-04-15 |
| 2013-09-30 | $17.86M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $18.35M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $8.86M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $9.14M 10-K · filed 2014-03-31 |
| 2012-09-30 | $9.39M 10-Q · filed 2012-11-19 |
| 2011-12-31 | $10.41M 10-K · filed 2013-04-15 |